MENU
ENGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
enGene Therapeutics (ENGN) Earnings Date & Reports
enGene Therapeutics Inc is a clinical-stage biotechnology company mainstreaming gene therapy through the delivery of therapeutics to mucosal tissues and other organs, to create new ways to address diseases with high clinical needs... Show more
A.I. Advisor
published Earnings
ENGN is expected to report earnings to fall 2.66% to -45 cents per share on December 23
Q4'26
Est.
$-0.46
Q3'26
Est.
$-0.47
Q2'26
Beat
by $0.11
Q1'26
Beat
by $0.10
Q4'25
Missed
by $0.22
The last earnings report on September 08 showed earnings per share of -46 cents, meeting the estimate of -46 cents. With 190.38K shares outstanding, the current market capitalization sits at 109.24M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
4868 Rue Levy
Phone
+1 514 332-4888
Employees
82
Web
https://www.engene.com